- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00767338
Microsurgical Varicocelectomy Versus No Surgery in Men With a Palpable Varicocele and an Abnormal Semen Analysis (VIA)
A Prospective, Randomized, Study of Microsurgical Varicocelectomy Versus Observation in the Treatment of Male Partners With a Palpable Varicocele and an Abnormal Semen Analysis
The primary research hypothesis is that microsurgical varicocelectomy will result in an increase in live birth in infertile couples where the male partner has a palpable varicocele and an abnormal semen analysis in comparison to male partners who do not have microsurgical varicocelectomy.
The secondary hypotheses include:
- To assess whether up to 4 cycles of intrauterine insemination confers any additional increase in live birth rates compared to timed intercourse;
- To examine spousal pregnancy rate as the secondary outcome; and
To study the effect of varicocelectomy in men with infertility, an abnormal semen analysis, and a palpable varicocele on
- Testicular semen analysis parameters;
- Serological measures of FSH, LH, total and free testosterone and
- Measures of quality of life and sexual function in both partners.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Study Design
This will be a randomized controlled clinical trial to examine the effect of varicocelectomy in men with infertility, an abnormal semen analysis, and a palpable varicocele. This approach will allow us to compare (i) the effect of microsurgical varicocelectomy on live birth rates after up to four cycles of alternating intrauterine insemination and four cycles of timed intercourse over 8 months and (ii) the relative effectiveness of intrauterine insemination versus timed intercourse on live birth rates. Secondary analyses will explore the effect of the surgical intervention on pregnancy rates, semen analysis parameters, serological hormonal measures in the male subjects, and quality of life measures in both the male and female partners.
Treatment
Two hundred and thirty-two couples will be randomized to the two intervention groups (microsurgical varicocelectomy plus up to four cycles each of alternating intrauterine insemination and timed intercourse or no microsurgical varicocelectomy plus up to four cycles each of alternating intrauterine insemination and timed intercourse).
Timing
We anticipate that it will take 3 years to complete the study. Enrollment will begin in year 1 of the study. 34 couples will need to be recruited per site over the duration of the study to reach the enrollment goal of 232 couples. Participants will be enrolled in the study for one year, with the male partner undergoing periodic study assessments at two month intervals.
Study Type
Enrollment (Actual)
Phase
- Phase 3
Contacts and Locations
Study Locations
-
-
Colorado
-
Aurora, Colorado, United States, 80045
- University of Colorado
-
-
Connecticut
-
New Haven, Connecticut, United States, 06511
- Yale University
-
-
Michigan
-
Ann Arbor, Michigan, United States, 48109
- University of Michigan
-
Detroit, Michigan, United States, 48201
- Wayne State University
-
-
New Jersey
-
Newark, New Jersey, United States, 07601
- University of Medicine and Dentistry of New Jersey
-
-
Pennsylvania
-
Hershey, Pennsylvania, United States, 17033
- Pennsylvania State University College of Medicine
-
Philadelphia, Pennsylvania, United States, 19104
- University of Pennsylvania
-
-
Texas
-
San Antonio, Texas, United States, 78207
- University of Texas Health Science Center at San Antonio
-
-
Vermont
-
Burlington, Vermont, United States, 05405
- University of Vermont
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- 6 months of infertility (primary or secondary - randomization will be stratified to allow equal numbers of primary and secondary infertility couples in the treatment vs. observation group), male partner > 18 years of age and < 50 years of age
- Female partner > 18 years of age and <= 40 years of age - randomization will be stratified for two groups - female partner <35 and female partner >=35
- Evidence of a hysterosalpingogram or Saline Infusion Sonogram with one patent tube and regular ovulatory cycles as defined by the recruiting site >25 days and <35 days in duration in the female partner
- Evidence of a bilateral grade I or unilateral grade II-III varicocele on physical exam in the male partner
- Abnormal semen analysis as defined by WHO II criteria with a sperm count of >5 X106 /ml or the presence of abnormal strict morphology as defined by Kruger criteria.
Exclusion Criteria:
- The presence of retrograde ejaculation or uncorrectable ejaculatory dysfunction
- Decreased ovarian reserve in the female partner as evidence by a day #3 FSH > 12 mIU/ml
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: No surgery + IUI
No microsurgical varicocelectomy plus up to four cycles each of alternating intrauterine insemination and timed intercourse starting with intrauterine insemination.
|
Timed intercourse
Other Names:
Intrauterine insemination
Other Names:
|
Active Comparator: No Surgery + TI
No microsurgical varicocelectomy plus up to four cycles each of alternating intrauterine insemination and timed intercourse starting with timed intercourse.
|
Timed intercourse
Other Names:
Intrauterine insemination
Other Names:
|
Active Comparator: Surgery + IUI
Microsurgical varicocelectomy plus up to four cycles each of alternating intrauterine insemination and timed intercourse starting with intrauterine insemination.
|
Timed intercourse
Other Names:
Intrauterine insemination
Other Names:
Microsurgical varicocelectomy
Other Names:
|
Active Comparator: Surgery + TI
Microsurgical varicocelectomy plus up to four cycles each of alternating intrauterine insemination and timed intercourse starting with timed intercourse.
|
Timed intercourse
Other Names:
Intrauterine insemination
Other Names:
Microsurgical varicocelectomy
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Number of Live Births After Eight Cycles of Infertility Treatment.
Time Frame: January 2009 to January 2012
|
January 2009 to January 2012
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Dana A Ohl, MD, University of Michigan
- Study Director: Michael Diamond, MD, Wayne State University
- Study Director: William D Schlaff, MD, University of Colorado Denver Health Science Center
- Principal Investigator: Gregory M Christman, MD, University of Michigan
Publications and helpful links
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- RMN-VIA
- 5U10HD055925-02 (U.S. NIH Grant/Contract)
- 5U10HD055936 (U.S. NIH Grant/Contract)
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Infertility
-
Assuta Hospital SystemsMaccabi Healthcare Services, IsraelCompletedInfertility, Female Infertility, Male InfertilityIsrael
-
Radboud University Medical CenterZonMw: The Netherlands Organisation for Health Research and DevelopmentCompletedPregnancy | Male Infertility | Female InfertilityNetherlands
-
Sapientiae InstituteTerminated
-
Esraa Gamal AhmedAin Shams Maternity HospitalUnknownUnexplained Female Infertility
-
King's College LondonNot yet recruitingInfertility | Infertility, Female | Infertility Unexplained | Infertility of Tubal Origin
-
Gazi UniversityCompletedMale Infertility | Unexplained Infertility
-
Wake Forest University Health SciencesWithdrawnUterine Diseases | Endometriosis | Infertility Unexplained | Endometrial Diseases | Infertility; Female, NonimplantationUnited States
-
University of WashingtonEunice Kennedy Shriver National Institute of Child Health and Human Development...CompletedMale Infertility, AzoospermiaUnited States
-
Pacific Fertility CenterTerminatedPrimary Female Infertility | Secondary Female Infertility
-
Istanbul University - Cerrahpasa (IUC)RecruitingInfertility | Sexual Dysfunction | Infertility, Male | Nurse's Role | Sexuality | Infertility; FemaleTurkey
Clinical Trials on Timed intercourse
-
Eunice Kennedy Shriver National Institute of Child...Completed
-
Fundación Santiago Dexeus FontRecruiting
-
Hospital de Santa Maria, PortugalCompletedSpontaneous Labour Onset | Vaginal Intercourse at TermPortugal
-
University of South FloridaUnknownInfertility | Pregnancy Related | IVF
-
University of AlbertaKARL STORZ Endoscopy-America, Inc.; VerathonCompletedTracheal Intubation MorbidityCanada
-
Sheba Medical CenterRecruitingEmbryo Transfer | Fertilization in Vitro | CoitusIsrael
-
Fondation Ophtalmologique Adolphe de RothschildTerminatedChildhood or Juvenile Absence EpilepsyFrance
-
University Hospital, Clermont-FerrandCentre de Recherche en Nutrition Humaine d'AuvergneCompleted
-
Universidade Federal FluminenseCompleted
-
CelgeneCompletedPrimary Myelofibrosis | AnemiaUnited States, France, Italy, United Kingdom